Werner Wessling

Dr Wessling holds a Masters in Chemistry and Pharmacy, and a PhD (Dr.rer.nat.) from the University of Bonn. His early career in management (1981-87) with Beiersdorf AG and Altana AG subsequently led to his appointment as VP Business Development worldwide for LTS Lohmann Therapie-Systeme, the developer and manufactuer of innovative transdermal systems and oral films incorporating active substances. Dr Wessling built a successful commercial career with LTS, helping to grow the global pharmaceutical company to become the world’s largest Transdermal Patch Manufacturer, with 1,300 employees. He was appointed Senior VP Corporate Development in 2000, a position he held until 2016. During that period Dr Wessling was a Board Delegate LTS Lohmann Therapy-Systems Inc. N.J., USA (1994-2016), Managing Director CRS GmbH (2006-14) and Managing Director IIS GmbH (2011-16) – both subsidiaries of LTS.

He is a respected senior expert for the Bundesverband der Pharmazeutischen Industrie e.V. (BPI), the Federal Association of the Pharmaceutical Industry in Germany, and led the Innovation and R&D Committee between 2004 – 2010.